Chris Freeman sold $11M of GH
Chief Commercial Officer at Guardant Health, Inc.. 63,605 shares at an average of $169.58, traded Aug 10, 2026, filed Aug 11, 2026.
Score components
- +15RoleOfficer
- +25Trade size$10.8M at market
- +10Share of holdings soldSold 49% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001871615-26-000016, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | MOption exercise Common Stock | +35,412 | $110.49 | $3.9M | 100,786 | Aug 11, 2026 |
| Aug 10, 2026 | MOption exercise Common Stock | +28,193 | $28.37 | $800k | 128,979 | Aug 11, 2026 |
| Aug 10, 2026 | SOpen-market sale Common Stock | -3,463 | $167.38 | $580k | 125,516 | Aug 11, 2026 |
| Aug 10, 2026 | SOpen-market sale Common Stock | -7,365 | $168.79 | $1.2M | 118,151 | Aug 11, 2026 |
| Aug 10, 2026 | SOpen-market sale Common Stock | -35,364 | $169.63 | $6.0M | 82,787 | Aug 11, 2026 |
| Aug 10, 2026 | SOpen-market sale Common Stock | -17,413 | $170.24 | $3.0M | 65,374 | Aug 11, 2026 |
| Aug 10, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -35,412 | $0.00 | $0 | 3,620 | Aug 11, 2026 |
| Aug 10, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -28,193 | $0.00 | $0 | 1,668 | Aug 11, 2026 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 85Strong | Guardant Health, Inc. | AmirAli Talasaz Co-Chief Executive Officer | $6.3M 37,500 shares | -50% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $18k 116 shares | -1% | |
| 60Notable | Guardant Health, Inc. | Terilyn J. Monroe Chief People Officer | $7.6M 46,300 shares | -67% | |
| 39Weak | Guardant Health, Inc. | Medina Manuel Hidalgo director | $279k 1,700 shares | -27% | |
| 60Notable | Guardant Health, Inc. | Ian T Clark director | $2.3M 14,180 shares | -83% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.